Dsp healthcare fund review

Top Searched Funds: Axis Long Term Equity Fund | SBI Bluechip Fund | Mirae Asset Emerging Bluechip Fund | Nippon India Small Cap Fund | HDFC Balanced Fund | Kotak Standard Multicap Fund | L&T Emerging Business Fund | L&T India Value Fund | Franklin India Smaller Companies Fund | HDFC Midcap Opportunities Fund Registered Office: 136, 1st Floor, Devika Tower, Nehru Place, Delhi - 110019, Tel No: 0120-4770-440 Operations Head office: The Hub, 8/2, Sarjapur Main Road, Ambulipura Village, Varthur Hobli, Bengaluru - 560103 SEBI regional office: Jeevan Mangal Building, Hayes Rd, off Residency Rd, Shanthala Nagar, Ashok Nagar, Bengaluru - 560025

SBI Healthcare Opportunities Fund : Overview, Performance, Portfolio | Mutual Fund | Value Research SBI Healthcare Opportunities Fund : Overview, Performance, Portfolio | Mutual Fund | Value Research https://www.valueresearchonline.com/funds/632/sbi-healthcare-opportunities-fund/ Get the latest information and complete track record of SBI Healthcare Opportunities Fund schemes, returns, latest NAV and ratings from independent mutual fund research house. Suitability This is a fund that invests mainly in shares of pharmaceutical and healthcare companies. We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains. But if you do invest, you must do so only through the SIP route. Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

DSP Healthcare Fund - Regular Plan : Overview, Performance, Portfolio | Mutual Fund | Value Research DSP Healthcare Fund - Regular Plan : Overview, Performance, Portfolio | Mutual Fund | Value Research https://www.valueresearchonline.com/funds/38197/dsp-healthcare-fund-regular-plan/ Get the latest information and complete track record of DSP Healthcare Fund - Regular Plan schemes, returns, latest NAV and ratings from independent mutual fund research house.

DSP Healthcare Fund Regular-IDCW Fund Key Highlights 1. Current NAV: The Current Net Asset Value of the DSP Healthcare Fund - Regular Plan as of Jun 16, 2023 is Rs 17.43 for IDCW option of its Regular plan. 2. Returns: Its trailing returns over different time periods are: 23.5% (1yr), 19.68% (3yr) and 20.45% (since launch). Whereas, Category returns for the same time duration are: 16.87% (1yr), 16.25% (3yr) and 15.32% (5yr). 3. Fund Size: The DSP Healthcare Fund - Regular Plan currently holds Assets under Management worth of Rs 1255.79 crore as on May 31, 2023. 4. Expense ratio: The expense ratio of the fund is 2.2% for Regular plan as on Sep 30, 2022. 5. Exit Load: DSP Healthcare Fund - Regular Plan shall attract an Exit Load, "Exit load of 1% if redeemed within 12 months." 6. Minimum Investment: Minimum investment required is Rs 100 and minimum additional investment is Rs 100. Minimum SIP investment is Rs 100. DSP Healthcare Fund Regular-IDCW Fund Details Investment Objective - The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. Fund House DSP Mutual Fund Launch Date Nov 30, 2018 Benchmark S&P BSE Healthcare Total Return Index Return Since Launch 20.45% Riskometer Very High Type Open-ended Risk Grade - Return Grade - Concentration & Valuation Analysis MAY 2023 APR 2023 MAR 2023 FEB 2023 DEC 2022 NOV 2022 Number of Holdings 25 26 24 25 25 25 Top 5 Company Holdings 45...

DSP Healthcare Fund Direct - Growth is a Sectoral-Pharma mutual fund scheme from • • DSP Healthcare Fund Direct - Growth returns of last 1-year are 25.19%. Since launch, it has delivered 22.33% average annual returns. The fund has doubled the money invested in it every 4 yrs. • DSP Healthcare Fund Direct - Growth scheme's ability to deliver returns consistently is in-line with most funds of its category. Its ability to control losses in a falling market is high. • The fund has the majority of its money invested in Healthcare, Insurance, Financial sectors. It has taken less exposure in Healthcare, Insurance sectors compared to other funds in the category. • • The fund's top 5 holdings are in Sun Pharmaceutical Inds. Ltd., Cipla Ltd., Apollo Hospitals Enterprise Ltd., Merck Ltd., Lupin Ltd.. ..... Vinit Sambre Mr. Sambre is a B.Com and FCA. Prior to joining DSP he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares and Securities Pvt. Ltd. (March 1999 to May 2000) and Credit Rating Information Service of India Ltd.(Apr 1998 to Feb 1999). • • Sun Pharmaceutical Inds. Ltd. 15.83% • Cipla Ltd. 9.96% • Apollo Hospitals Enterprise Ltd. 6.85% • Merck Ltd. 6.62% • Lupin Ltd. 6.53% • Alembic Pharmaceuticals Ltd. 5.09% • Alkem Laboratories Ltd. 5.02% • Ipca Laboratories Ltd. 4.41% • Mankind Pharma Ltd. 4.22% • Suven P...

SBI Healthcare Opportunities Fund : Overview, Performance, Portfolio | Mutual Fund | Value Research SBI Healthcare Opportunities Fund : Overview, Performance, Portfolio | Mutual Fund | Value Research https://www.valueresearchonline.com/funds/632/sbi-healthcare-opportunities-fund/ Get the latest information and complete track record of SBI Healthcare Opportunities Fund schemes, returns, latest NAV and ratings from independent mutual fund research house.

DSP Healthcare Fund Direct - Growth is a Sectoral-Pharma mutual fund scheme from • • DSP Healthcare Fund Direct - Growth returns of last 1-year are 25.19%. Since launch, it has delivered 22.33% average annual returns. The fund has doubled the money invested in it every 4 yrs. • DSP Healthcare Fund Direct - Growth scheme's ability to deliver returns consistently is in-line with most funds of its category. Its ability to control losses in a falling market is high. • The fund has the majority of its money invested in Healthcare, Insurance, Financial sectors. It has taken less exposure in Healthcare, Insurance sectors compared to other funds in the category. • • The fund's top 5 holdings are in Sun Pharmaceutical Inds. Ltd., Cipla Ltd., Apollo Hospitals Enterprise Ltd., Merck Ltd., Lupin Ltd.. ..... Vinit Sambre Mr. Sambre is a B.Com and FCA. Prior to joining DSP he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares and Securities Pvt. Ltd. (March 1999 to May 2000) and Credit Rating Information Service of India Ltd.(Apr 1998 to Feb 1999). • • Sun Pharmaceutical Inds. Ltd. 15.83% • Cipla Ltd. 9.96% • Apollo Hospitals Enterprise Ltd. 6.85% • Merck Ltd. 6.62% • Lupin Ltd. 6.53% • Alembic Pharmaceuticals Ltd. 5.09% • Alkem Laboratories Ltd. 5.02% • Ipca Laboratories Ltd. 4.41% • Mankind Pharma Ltd. 4.22% • Suven P...

Top Searched Funds: Axis Long Term Equity Fund | SBI Bluechip Fund | Mirae Asset Emerging Bluechip Fund | Nippon India Small Cap Fund | HDFC Balanced Fund | Kotak Standard Multicap Fund | L&T Emerging Business Fund | L&T India Value Fund | Franklin India Smaller Companies Fund | HDFC Midcap Opportunities Fund Registered Office: 136, 1st Floor, Devika Tower, Nehru Place, Delhi - 110019, Tel No: 0120-4770-440 Operations Head office: The Hub, 8/2, Sarjapur Main Road, Ambulipura Village, Varthur Hobli, Bengaluru - 560103 SEBI regional office: Jeevan Mangal Building, Hayes Rd, off Residency Rd, Shanthala Nagar, Ashok Nagar, Bengaluru - 560025

DSP Healthcare Fund Regular-IDCW Fund Key Highlights 1. Current NAV: The Current Net Asset Value of the DSP Healthcare Fund - Regular Plan as of Jun 16, 2023 is Rs 17.43 for IDCW option of its Regular plan. 2. Returns: Its trailing returns over different time periods are: 23.5% (1yr), 19.68% (3yr) and 20.45% (since launch). Whereas, Category returns for the same time duration are: 16.87% (1yr), 16.25% (3yr) and 15.32% (5yr). 3. Fund Size: The DSP Healthcare Fund - Regular Plan currently holds Assets under Management worth of Rs 1255.79 crore as on May 31, 2023. 4. Expense ratio: The expense ratio of the fund is 2.2% for Regular plan as on Sep 30, 2022. 5. Exit Load: DSP Healthcare Fund - Regular Plan shall attract an Exit Load, "Exit load of 1% if redeemed within 12 months." 6. Minimum Investment: Minimum investment required is Rs 100 and minimum additional investment is Rs 100. Minimum SIP investment is Rs 100. DSP Healthcare Fund Regular-IDCW Fund Details Investment Objective - The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. Fund House DSP Mutual Fund Launch Date Nov 30, 2018 Benchmark S&P BSE Healthcare Total Return Index Return Since Launch 20.45% Riskometer Very High Type Open-ended Risk Grade - Return Grade - Concentration & Valuation Analysis MAY 2023 APR 2023 MAR 2023 FEB 2023 DEC 2022 NOV 2022 Number of Holdings 25 26 24 25 25 25 Top 5 Company Holdings 45...

DSP Healthcare Fund - Regular Plan : Overview, Performance, Portfolio | Mutual Fund | Value Research DSP Healthcare Fund - Regular Plan : Overview, Performance, Portfolio | Mutual Fund | Value Research https://www.valueresearchonline.com/funds/38197/dsp-healthcare-fund-regular-plan/ Get the latest information and complete track record of DSP Healthcare Fund - Regular Plan schemes, returns, latest NAV and ratings from independent mutual fund research house. Suitability This is a fund that invests mainly in shares of pharmaceutical and healthcare companies. We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains. But if you do invest, you must do so only through the SIP route. Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.